Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-78,855
Closed -$733K 848
2026
Q1
$733K Buy
78,855
+40,050
+103% +$394K 0.02% 301
2025
Q4
$271K Buy
+38,805
New +$244K 0.01% 394
2025
Q3
Sell
-63,926
Closed -$306K 593
2025
Q2
$306K Buy
+63,926
New +$367K 0.01% 298
2025
Q1
Sell
-39,639
Closed -$481K 477
2024
Q4
$481K Buy
39,639
+18,145
+84% +$254K 0.02% 199
2024
Q3
$361K Buy
+21,494
New +$354K 0.01% 205
2024
Q2
Sell
-32,342
Closed -$510K 371
2024
Q1
$510K Buy
+32,342
New +$541K 0.01% 89

Other funds holding NEOG

Aristeia Capital's NEOG Position: Q2 2026 in Review

Aristeia Capital sold out of Neogen (NEOG) in Q2 2026, closing a stake of 78,855 shares — an estimated $733K sold.

Aristeia Capital first reported a position in NEOG in Q1 2024 and held it in 6 quarters. The position peaked at $733K in Q1 2026. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Aristeia Capital reported no remaining Neogen position as of Q2 2026 after selling out during the quarter.
  • Aristeia Capital sold 78,855 Neogen shares in Q2 2026, an estimated $733K.
  • Aristeia Capital first reported a position in Neogen in Q1 2024 and held it in 6 quarters.
  • Aristeia Capital's Neogen position peaked at $733K in Q1 2026.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.